Matthies Rennegarbe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthies Rennegarbe has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Bouke P. C. Hazenberg
University Medical Center Groningen, The Netherlands
2 shared publications - Falk Liberta
Institute of Protein Biochemistry, Ulm University, 89081 Ulm, Germany
2 shared publications - Marcus Fändrich
Institute of Protein Biochemistry, Ulm University
2 shared publications Angelika Schierhorn
Institute of Biochemistry and Biotechnology, Martin-Luther-University, 06120, Halle (Saale), Germany
1 shared publicationGunilla T. Westermark
Department of Medical Cell Biology, Uppsala University, SE-75123, Uppsala, Sweden
1 shared publication- Johan Bijzet
Amyloidosis Center of Expertise, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
1 shared publication
Latest Publications
- 7 June 2019
- Published by Taylor & Francis in Amyloid
- Vol. 26 (3) , 164-170
Morphological and primary structural consistency of fibrils from different AA patients (common variant)
Aims: To test the hypothesis that the fibril morphology and the fibril protein primary structure are conserved across different patients suffering from the common variant of systemic Amyloid A (AA) amyloidosis. Methods: Amyloid fibrils were extracted from the renal tissue of four patients. The fibril morphology was analysed in negatively stained samples with transmission electron microscopy (TEM). The fibril protein identity and fragment length were determined by using mass spectrometry. Results: The fibrils show a consistent morphology in all four patients and exhibit an average width of ∼9.6 nm and an average pitch of ∼112 nm. All fibrils are composed of polypeptide chains that can be assigned to human serum amyloid A (SAA) 1.1 protein. All fragments lack the N-terminal arginine residue and are C-terminally truncated. Differences exist concerning the exact C-terminal cleavage site. The most prominent cleavage site occurs at residues 64–67. Conclusions: Our data demonstrate that AA amyloid fibrils are consistent at the level of the protein primary structure and fibril morphology in the four analysed patients.
- 7 June 2019
- Published by Taylor & Francis in Amyloid
- Vol. 26 (3) , 164-170
Morphological and primary structural consistency of fibrils from different AA patients (common variant)
Aims: To test the hypothesis that the fibril morphology and the fibril protein primary structure are conserved across different patients suffering from the common variant of systemic Amyloid A (AA) amyloidosis. Methods: Amyloid fibrils were extracted from the renal tissue of four patients. The fibril morphology was analysed in negatively stained samples with transmission electron microscopy (TEM). The fibril protein identity and fragment length were determined by using mass spectrometry. Results: The fibrils show a consistent morphology in all four patients and exhibit an average width of ∼9.6 nm and an average pitch of ∼112 nm. All fibrils are composed of polypeptide chains that can be assigned to human serum amyloid A (SAA) 1.1 protein. All fragments lack the N-terminal arginine residue and are C-terminally truncated. Differences exist concerning the exact C-terminal cleavage site. The most prominent cleavage site occurs at residues 64–67. Conclusions: Our data demonstrate that AA amyloid fibrils are consistent at the level of the protein primary structure and fibril morphology in the four analysed patients.
- Open Access
- 7 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids
Systemic AA amyloidosis is a worldwide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from the acute phase protein serum amyloid A. Here, we report the purification and electron cryo-microscopy analysis of amyloid fibrils from a mouse and a human patient with systemic AA amyloidosis. The obtained resolutions are 3.0 Å and 2.7 Å for the murine and human fibril, respectively. The two fibrils differ in fundamental properties, such as presence of right-hand or left-hand twisted cross-β sheets and overall fold of the fibril proteins. Yet, both proteins adopt highly similar β-arch conformations within the N-terminal ~21 residues. Our data demonstrate the importance of the fibril protein N-terminus for the stability of the analyzed amyloid fibril morphologies and suggest strategies of combating this disease by interfering with specific fibril polymorphs.
- 7 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Open AccessCryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids
Systemic AA amyloidosis is a worldwide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from the acute phase protein serum amyloid A. Here, we report the purification and electron cryo-microscopy analysis of amyloid fibrils from a mouse and a human patient with systemic AA amyloidosis. The obtained resolutions are 3.0 Å and 2.7 Å for the murine and human fibril, respectively. The two fibrils differ in fundamental properties, such as presence of right-hand or left-hand twisted cross-β sheets and overall fold of the fibril proteins. Yet, both proteins adopt highly similar β-arch conformations within the N-terminal ~21 residues. Our data demonstrate the importance of the fibril protein N-terminus for the stability of the analyzed amyloid fibril morphologies and suggest strategies of combating this disease by interfering with specific fibril polymorphs.